MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Net Income
-$154,165
Unit: Dollar

Income Statement
2026-05-31
2026-02-28
2025-11-30
2025-08-31
Services
0 0 0 0*
Cost of services
0 0 NaN NaN
Gross profit
0 0 NaN NaN
Research and development expense
NaN 0 NaN 0*
General and administrative expenses
162,763 72,963 64,002 162,286.25*
Total operating expenses
162,763 72,963 64,002 162,286.25*
Loss from operations
-162,763 -72,963 -64,002 -162,286.25*
Capital loss
NaN 0 NaN 0*
Financial loss, net
NaN NaN NaN 10,571.25*
Financial income (loss), net
8,598 28,865 -49,717 NaN
Net (loss)
-154,165 -44,098 -113,719 -172,857.5
Profit (loss) from available for sale assets
NaN 0 0 NaN
Total comprehensive income (loss)
-154,165 -44,098 -113,719 -172,857.5
Basic EPS
0 0 0 -0.001
Diluted EPS
0 0 0 -0.001
Basic Average Shares
1,318,594,182 931,015,714 732,857,211 198,239,676
Diluted Average Shares
1,318,594,182 931,015,714 732,857,211 198,239,676
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Total comprehensiveincome (loss)-$154,165 (-158.12%↓ Y/Y)Net (loss)-$154,165 (-158.12%↓ Y/Y)Financial income (loss),net$8,598 (144.44%↑ Y/Y)Loss from operations-$162,763 (-303.08%↓ Y/Y)Total operatingexpenses$162,763 (303.08%↑ Y/Y)General andadministrative expenses$162,763 (303.08%↑ Y/Y)

CNBX Pharmaceuticals Inc. (CNBX)

CNBX Pharmaceuticals Inc. (CNBX)